drugset / Trial / NCT01574313

Effect of Stellate Ganglion Block on Meniere's Disease

NCT01574313 ↗

Phase 4 Completed 20 enrolled Chi Mei Medical Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Stellate ganglion block (SGB) has been the alternative treatment of Meniere's disease for years. However, objective evidence of the effect of SGB was still lack. The investigators conducted a randomized controlled study to examine the immediate effects of SGB in SP/AP of electrocochleography (ECoG).

Timeline

Start
2010-04
Primary completion
2011-04
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator FLUDIAZEPAM Small molecule 0.25 mg Oral
Comparator diphenidol Small molecule 25 mg Oral
Comparator tocopherol nicotinate Unknown 200 mg Oral

Indications